Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone in mild to moderate heart failure
NCT00082589Phase 4Completed
- Sponsor
- Viatris
- Start
- Apr 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in heart failure (HF) comparing Eplerenone with Placebo (2 arms). Primary endpoint: Change in Left Ventricular End-Diastolic Volume Index at 36 weeks. Started Apr 2004; status: completed.
02
Drugs
eplerenone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00082589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00082589.